Get it on Google Play

Quantum BioPharma signs Thermo Fisher deal for MS Phase 2 trial

October 6, 2026 6:00 AM EDT Send to a Friend
Quantum BioPharma Ltd. (NASDAQ: QNTM) has entered into a Study Start-Up Agreement with the clinical research business of Thermo Fisher ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login